These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2484701)

  • 1. Oxygen and oxidation promote the release of nitric oxide from sydnonimines.
    Bohn H; Schönafinger K
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S6-12. PubMed ID: 2484701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of NO release from sydnonimines.
    Feelisch M; Ostrowski J; Noack E
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S13-22. PubMed ID: 2484692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular aspects underlying the vasodilator action of molsidomine.
    Noack E; Feelisch M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S1-5. PubMed ID: 2484685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peroxynitrite generator, SIN-1, becomes a nitric oxide donor in the presence of electron acceptors.
    Singh RJ; Hogg N; Joseph J; Konorev E; Kalyanaraman B
    Arch Biochem Biophys; 1999 Jan; 361(2):331-9. PubMed ID: 9882464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen modulation of guanylate cyclase-mediated retinal pericyte relaxations with 3-morpholino-sydnonimine and atrial natriuretic peptide.
    Haefliger IO; Anderson DR
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1563-8. PubMed ID: 9224284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes.
    Pieper GM; Clarke GA; Gross GJ
    J Pharmacol Exp Ther; 1994 May; 269(2):451-6. PubMed ID: 8182511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of SIN-1 on isolated canine basilar arteries.
    Katusic ZS; Vanhoutte PM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S72-5. PubMed ID: 2484704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilator effect and tolerance induced by the nitrocompound SIN-1 in rabbit femoral artery.
    Govantes C; Rodríguez-Martínez MA; Marín J
    Methods Find Exp Clin Pharmacol; 1996; 18(6):387-95. PubMed ID: 8892268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli.
    Brunelli L; Crow JP; Beckman JS
    Arch Biochem Biophys; 1995 Jan; 316(1):327-34. PubMed ID: 7840633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of aerosolized nitric oxide donor drugs to achieve sustained pulmonary vasodilation.
    Schütte H; Grimminger F; Otterbein J; Spriestersbach R; Mayer K; Walmrath D; Seeger W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):985-94. PubMed ID: 9262367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between endothelium-derived nitric oxide and SIN-1 in human and porcine blood vessels.
    Lüscher TF; Richard V; Yang ZH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S76-80. PubMed ID: 2484705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoactivation of the nitric oxide donor SIN-1.
    Ullrich T; Oberle S; Abate A; Schröder H
    FEBS Lett; 1997 Apr; 406(1-2):66-8. PubMed ID: 9109387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide donors as generators and scavengers of superoxide anions.
    Robak J; Gryglewski RJ
    Pol J Pharmacol; 1993; 45(1):51-8. PubMed ID: 8401759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye.
    Behar-Cohen FF; Goureau O; D'Hermies F; Courtois Y
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1711-5. PubMed ID: 8675417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide regulates the calcium current in isolated human atrial myocytes.
    Kirstein M; Rivet-Bastide M; Hatem S; Bénardeau A; Mercadier JJ; Fischmeister R
    J Clin Invest; 1995 Feb; 95(2):794-802. PubMed ID: 7860763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism underlying the inhibitory interaction between the nitrovasodilator SIN-1 and the endothelium.
    Flavahan NA; Vanhoutte PM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S86-90. PubMed ID: 2484707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the lower esophageal sphincter pressure after oral molsidomine by sydnonimine plasma concentrations.
    Stoschus B; Fernandez I; Heller J; Neubrand M; Sauerbruch T
    Hepatogastroenterology; 1999; 46(26):933-7. PubMed ID: 10370642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite.
    Thomas SR; Davies MJ; Stocker R
    Chem Res Toxicol; 1998 May; 11(5):484-94. PubMed ID: 9585479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of platelet function by SIN-1A, a metabolite of molsidomine.
    Wautier JL; Weill D; Kadeva H; Maclouf J; Soria C
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S111-4. PubMed ID: 2484687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferritin oxidation in vitro: implication of iron release and degradation by the 20S proteasome.
    Rudeck M; Volk T; Sitte N; Grune T
    IUBMB Life; 2000 May; 49(5):451-6. PubMed ID: 10902578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.